Publication details
Development of an innovative nanostructured dermal matrix in combination with a hyperstable form of growth factor for fibroblasts (FGF2): Ex ovo and in vivo study
Authors | |
---|---|
Year of publication | 2019 |
Type | Conference abstract |
Citation |